既往接受过治疗的急性淋巴细胞白血病的免疫治疗 - Suppr | 超能文献

Immunotherapy in previously treated acute lymphatic leukemia.

作者信息

Leventhal B G, LePourhiet A, Halterman R H, Henderson E S, Herberman R B

出版信息

Natl Cancer Inst Monogr. 1973 Dec;39:177-87.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Immunotherapy in previously treated acute lymphatic leukemia.既往接受过治疗的急性淋巴细胞白血病的免疫治疗

Natl Cancer Inst Monogr. 1973 Dec;39:177-87.

2

Treatment of acute lymphoblastic leukaemia. Comparison of immunotherapy (B.C.G.), intermittent methotrexate, and no therapy after a five-month intensive cytotoxic regimen ((Concord trial). Preliminary report to the Medical Research Council by the Leukaemia Committee and the Working Party on Leukaemia in Childhood.急性淋巴细胞白血病的治疗。免疫疗法（卡介苗）、间歇性甲氨蝶呤以及在五个月强化细胞毒性治疗方案后不进行治疗的比较（康科德试验）。白血病委员会和儿童白血病工作组向医学研究委员会提交的初步报告。

Br Med J. 1971 Oct 23;4(5781):189-94.

3

BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual disease.

Natl Cancer Inst Monogr. 1973 Dec;39:165-75.

4

[Considerations on some cases of acute lymphatic leukemia treated with aspecific active immunotheraphy].[关于某些采用非特异性主动免疫疗法治疗的急性淋巴细胞白血病病例的思考]

Minerva Pediatr. 1974 Jun 16;26(21):1087-93.

5

[Active immunotherapy in acute lymphoid leukemia in children. Influence of several factors on the results].[儿童急性淋巴细胞白血病的主动免疫治疗。多种因素对治疗结果的影响]

Arch Fr Pediatr. 1973 Jan;30(1):65-81.

6

The use of systemic immunity adjuvants in the prophylaxis or therapy of cancer.全身免疫佐剂在癌症预防或治疗中的应用。

Johns Hopkins Med J Suppl. 1974;3:85-102.

7

Preliminary result of a new protocol for the active immunotherapy of acute lymphoblastic leukaemia: inhibition of the immunotherapeutic effect by Vincristine or Adamantadine.急性淋巴细胞白血病主动免疫治疗新方案的初步结果：长春新碱或金刚烷胺对免疫治疗效果的抑制作用

Rev Eur Etud Clin Biol. 1971 Mar;16(3):216-24.

8

Treatment of the acute leukemias.急性白血病的治疗

Semin Hematol. 1972 Apr;9(2):181-91.

9

Results in children of acute lymphoid leukemia: protocol ICIG-ALL 9 consisting of chemotherapy for only 9 months followed by active immunotherapy: comparison with the results of more prolonged chemotherapy protocols. Recognition of two groups of acute lymphoid leukemias from prognostic parameters.急性淋巴细胞白血病患儿的治疗结果：仅包含9个月化疗及后续主动免疫疗法的ICIG-ALL 9方案：与更长疗程化疗方案的结果比较。根据预后参数对两组急性淋巴细胞白血病的识别。

Recent Results Cancer Res. 1977(62):67-77. doi: 10.1007/978-3-642-81174-6_11.

10

[Attempts at treatment of acute leukemia with L-asparaginase].[用L-天冬酰胺酶治疗急性白血病的尝试]

Acta Haematol Pol. 1971 Oct-Dec;2(4):305-10.

引用本文的文献

1

Immunotherapy and chemoimmunotherapy of malignant disease with BCG and nonviable mycobacterial fractions.卡介苗及非活性分枝杆菌组分对恶性疾病的免疫治疗和化学免疫治疗

World J Surg. 1977 Sep;1(5):555-83. doi: 10.1007/BF01556181.